Found "AI": 1,133 results
Before Birth, Dad’s ID
t is an uncomfortable question that, in today’s world, is often asked by expectant mothers who had more than one male partner at the time they became pregnant. Who is the father?With more than half of births to women under 30 now out of wedlock, it is a question that may arise more often.Now blood t
Balancing the right to know and the privacy of the patent system: a case study of oncology medicines in Thailand. (2013)
Balancing the right to know and the privacy of the patent system: a case study of oncology medicines in Thailand.
Inthira Yamabhai; Richard D. Smith
Abstract: This study aims to illustrate the processes to determine medicine patent status in developing countries by using oncology medicine in T
Balancing patient choice and health system capacity: a system dynamics model of dialysis in Thailand
Background
As universal health coverage schemes mature, governments often seek to improve patient choice, whilst ensuring that services are appropriate, high-quality, and financially sustainable, especially for high-cost interventions like dialysis. Policy levers to manage supply and demand for ser
Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making
Abstract
Introduction
Despite the documented benefits of using health technology assessments (HTA) to inform resource allocation in health care systems, HTA remains underused, especially in low- and middle-income countries. A survey of global health practitioners was conducted to reveal the top
At 4500 miles apart, Thailand joins the Kenyan UHC Fund Taskforce Meeting
On 21st September 2020, HITAP joined representatives of the Ministry of Public Health (MOPH) Thailand and the National Health Security Office (NHSO) at the Kenyan Universal Health Coverage (UHC) Fund Taskforce meeting chaired by Mr. Geoffrey Malombe from National Treasury and Dr. Mercy Mwangangi, Ch
AstraZeneca starts new study of heart drug versus rival
(Reuters) – AstraZeneca is to conduct a new global clinical trial of key new heart drug Brilinta involving 11,500 patients with peripheral artery disease, Britain’s second biggest drugmaker said on Tuesday.Peripheral artery disease affects around 27 million people in Europe and North America, with s
Assessment of HTA capacity in Africa
HITAP, in collaboration with the Center for the Evaluation of Value and Risk in Health, Tufts Medical Cent, conducted an analysis of existing capacity for conducting economic evaluations in the African region using the Tufts Medical Center CEA Registries. The findings of the study were presented at the PMAC 2020 side meeting “Attain & Sustain
10 / Page